atopic dermatitis

bee flying away bee nectar flower pollen plant lilac

Biotech

Nektar stock doubles as phase 2b eczema trial hits endpoints

The biotech reported a phase 2 win in atopic dermatitis, sending its stock up 119% despite the data falling short of the bar set by Dupixent.

Nick Paul Taylor Jun 24, 2025 9:20am

An arrow incrementally going up stairs before pointing straight up Blue background

Leo's eczema prospect hits primary endpoint in phase 2b

May 9, 2025 7:30am

rocket launch satellite space fly blast off

Amgen ignites Rocket program with wins in phase 3 eczema trials

Mar 10, 2025 5:48am

team layoffs workforce

Q32 Bio sticks with bempikibart but lets go of staff

Feb 11, 2025 4:47am

Ikena, after tough year of layoffs, merges with Inmagene

Dec 23, 2024 10:00am

Person throwing piece of paper into full waste bin

Anaptys scraps atopic dermatitis asset after ph. 2 fail

Dec 11, 2024 11:02am